Outliers with Daniel Scrivner: Explore the Greatest Innovators, Founders, and Investors cover image

#47 Mindbloom: On Psychedelics and Democratizing Access to Psychedelic Therapy | Jack Swain, Head of Clinical Operations

Outliers with Daniel Scrivner: Explore the Greatest Innovators, Founders, and Investors

00:00

Psychodelic Therapy

There's a confluence of factors that are helping to reduce the stigma and lead people to want to try these as legitimate mental health treatments. The fda is giving break through or fast track designations for silicibin, mdma an cademine. There has also been great news coverage of psychedelics. In they are like true medical potential.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app